Ozempic, known generically as semaglutide, entered the market as a diabetes medication in 2017 and quickly gained recognition for its substantial weight loss effects
Payers are talking about this because its impacting everyone
It contains the active ingredient, retatrutide, and is being developed by the same manufacturer as Mounjaro, Eli Lilly, for the management of obesity and type 2 diabetes
Researchers from the University of Southern California and the University of California San Diego evaluated a large, nationally representative electronic health records database to determine the incidence of primary open-angle glaucoma (POAG), ocular hypertension (OHT) and first-line glaucoma interventions in patients with type 2 diabetes mellitus (DM) treated with tirzepatide vs
Our clinic offers treatments that are carefully tailored to each individuals health profile and weight loss goals
What I saw in the trial data is that participants in Phase 2 received the drug at no cost and had close medical monitoring throughout